A CLINICAL-STUDY ON THE USE OF CODEINE, OXYCODONE, DEXTROPROPOXYPHENE, BUPRENORPHINE, AND PENTAZOCINE IN CANCER PAIN

被引：30

作者：

DECONNO, F ^{[1
]}

RIPAMONTI, C ^{[1
]}

SBANOTTO, A ^{[1
]}

BARLETTA, L ^{[1
]}

ZECCA, E ^{[1
]}

MARTINI, C ^{[1
]}

VENTAFRIDDA, V ^{[1
]}

机构：

[1] NATL CANC INST,DIV PAIN THERAPY & PALLIAT CARE,VIA VENEZIAN 1,I-20133 MILAN,ITALY

来源：

JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 1991年 / 6卷 / 07期

关键词：

OPIOIDS; PAIN RELIEF; SIDE EFFECTS; DOSAGE; DURATION OF TREATMENT;

D O I：

10.1016/0885-3924(91)90040-B

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

The authors report a prospective study on 944 cancer pain patients treated with one of the following opioids: codeine, oxycodone, dextropropoxyphene, buprenorphine, and pentazocine. Level of analgesia, duration of treatment, side effects, and drop out were evaluated for each drug. Twenty-four percent of the patients still benefitted from treatment at the fourth week of study, even if high drug dosages were not used. Pentazocine did not show an evident analgesic effect during the first 2 wk of treatment. The other opioids were found to be valid therapeutic instruments for chronic cancer pain control in a limited number of patients.

引用

页码：423 / 427

页数：5

共 15 条

[1] World Health Organization, Cancer pain relief, (1986)
[2] Ventafridda, Saita, Ripamonti, De Conno, WHO guidelines for the use of analgesics in cancer pain, Int J Tiss Reac, 7, pp. 93-99, (1986)
[3] Takeda, Preliminary report from Japan on results of field testing of WHO Draft interim guidelines for relief of cancer pain, The Pain Clin J, 1, pp. 83-89, (1986)
[4] Ventafridda, Tamburini, Caraceni, De Conno, Naldi, A validation study of the WHO method for cancer pain relief, Cancer, 59, pp. 850-856, (1987)
[5] Walker, Hoskin, Hanks, White, Evaluation of WHO analgesic guidelines for cancer pain in a hospital-based Palliative Care Unit, J Pain Symptom Manage, 3, pp. 145-149, (1988)
[6] Ventafridda, De Conno, Vigano', Ripamonti, Gallucci, Gamba, Comparison of home and hospital care of advanced cancer patients, Tumori, 75, pp. 619-625, (1989)
[7] Foley, The treatment of cancer pain, N Engl J Med, 313, pp. 84-95, (1985)
[8] Ventafridda, De Conno, Panerai, Maresca, Monza, Ripamonti, Non-steroidal anti-inflammatory drugs as the first step in cancer pain therapy: double-blind, within-patient study comparing nine drugs, J Int Med Res, 18, pp. 21-29, (1990)
[9] Beaver, Aspirin and acetaminophen as constituents of analgesic combinations, Arch Intern Med, 141, pp. 293-300, (1981)
[10] Beaver, Combination Analgesics, Am J Med, 77, pp. 38-53, (1984)

← 1 2 →